Smith+Nephew Announces a Marketing Collaboration with Movendo Technology

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

March 25, 2021

Smith+Nephew today announced a marketing collaboration with Movendo Technology (Genoa, Italy) that will add personalized robotic patient rehabilitation capability to Smith+Nephew’s Real Intelligence enabling technology solutions, creating a fully digitized patient pathway from the pre-op stage to post-rehab phase.

The collaboration has launched in Europe and will expand to other regions in the near future.

Movendo Technology’s multifunctional rehabilitation device, HUNOVA, is able to analyze 130 different biomechanics parameters of the lower limb before and after surgery, generating a bespoke functional evaluation knee index. This provides a personalized patient recovery program to support the return of strength and function of the joint’s articulation. The index can also be extended to the hip and ankle.

Smith+Nephew’s Real Intelligence ecosystem addresses clinical challenges through the continuum of care including patient engagement, pre-operative planning, digital and robotic surgery, post-operative assessment, and outcomes measurement. Smith+Nephew’s next-generation robotics-assisted platform, the CORI Surgical System, is scheduled to launch in Europe during the first half of 2021 after a successful introduction in the US last year.

“We are thrilled that this collaboration will start in Europe,” said Peter Coenen, President EMEA, Smith+Nephew. “By combining our innovations in robotics-assisted surgical systems with HUNOVA Robotic technology, we bring together personalized implant placement and soft tissue balancing with a rehabilitation treatment to deliver greater benefits to patients, accelerate recovery and improve function.”

“We are extremely proud and excited about this new partnership that will make robotics-assisted surgery and rehabilitation an integrated, more effective, and engaging process,” said Simone Ungaro, CEO of Movendo. “I am looking forward to bringing this innovative concept world-wide in collaboration with Smith+Nephew.”

The collaboration further emphasizes Smith+Nephew’s commitment to data-driven enabling technologies that allow our customers to provide the highest level of care to their patients.

spot_img

DON'T MISS

Related Articles